Director
Associate Directors
Members
Frederick W. Alt, Ph.D.
Boston Children’s Hospital & Harvard Medical School
Richard Axel, M.D.
Columbia University
Nina Bhardwaj, M.D., Ph.D.
Icahn School of Medicine at Mount Sinai
Harvey Cantor, M.D.
Dana-Farber Cancer Institute & Harvard Medical School
Jonathan Cebon, Ph.D., FRACP
Ludwig Institute for Cancer Research & Olivia Newton John Cancer Research Institute
Vincenzo Cerundolo, M.D., Ph.D.
University of Oxford
Max D. Cooper, M.D.
Emory University
Lisa M. Coussens, Ph.D.
Oregon Health and Science University
Peter Cresswell, Ph.D.
Yale University
Charles G. Drake, M.D., Ph.D.
New York-Presbysterian / Columbia University Medical Center
Michael L. Dustin, Ph.D.
University of Oxford
Richard A. Flavell, Ph.D., FRS
Yale University
Thomas Gajewski, M.D., Ph.D.
University of Chicago
Laurie H. Glimcher, M.D.
Dana-Farber Cancer Institute
Philip D. Greenberg, M.D.
Fred Hutchinson Cancer Research Center & University of Washington
Axel Hoos, M.D., Ph.D.
GlaxoSmithKline
Patrick Hwu, M.D.
The University of Texas MD Anderson Cancer Center
Elizabeth M. Jaffee, M.D.
Johns Hopkins University School of Medicine
Carl H. June, M.D.
University of Pennsylvania
Michael Kalos, Ph.D.
Eli Lilly & Co.
Michael Karin, Ph.D.
University of California, San Diego (UCSD)
John M. Kirkwood, M.D.
University of Pittsburgh School of Medicine
Alexander Knuth, M.D.
Hamad Medical Corporation
Lewis L. Lanier, Ph.D.
University of California, San Francisco (UCSF)
Hyam I. Levitsky, M.D.
Juno Therapeutics
Dan R. Littman, M.D., Ph.D.
New York University Medical Center
Nils Lonberg, Ph.D.
Bristol-Myers Squibb
Tak W. Mak, Ph.D., D.Sc., FRSC
University Health Network
Philippa C. Marrack, Ph.D.
National Jewish Medical and Research Center & University of Colorado
Cornelis J.M. Melief, M.D., Ph.D.
Leiden University Medical Center
Ira Mellman, Ph.D.
Genentech, Inc.
Malcolm A.S. Moore, D.Phil.
Memorial Sloan Kettering Cancer Center
Lee Nadler, M.D.
Harvard Medical School & Dana-Farber Cancer Institute
Kunle Odunsi, M.D., Ph.D.
Roswell Park Cancer Institute
Drew M. Pardoll, M.D., Ph.D.
Johns Hopkins University School of Medicine
Klaus Rajewsky, M.D.
Max Delbrueck Center for Molecular Medicine
Anjana Rao, Ph.D.
La Jolla Institute for Allergy and Immunology & University of California, San Diego (UCSD)
Jeffrey V. Ravetch, M.D., Ph.D.
The Rockefeller University
Stanley R. Riddell, M.D.
Fred Hutchinson Cancer Research Center & University of Washington
Alexander Rudensky, Ph.D.
Memorial Sloan Kettering Cancer Center
Bijan Safai, M.D., D.Sc.
New York Medical College
Shimon Sakaguchi, M.D., Ph.D.
Osaka University
Lawrence E. Samelson, M.D.
National Cancer Institute
Hans Schreiber, M.D., Ph.D.
University of Chicago
Ton N. Schumacher, Ph.D.
The Netherlands Cancer Institute & Leiden University Medical Center
Craig L. Slingluff Jr., M.D.
University of Virginia Health System
Mark John Smyth, Ph.D., FAHMS
QIMR Berghofer Medical Research Institute
Pramod K. Srivastava, M.D., Ph.D.
University of Connecticut School of Medicine
Susumu Tonegawa, Ph.D.
Massachusetts Institute of Technology
Giorgio Trinchieri, M.D.
National Cancer Institute
Emil R. Unanue, M.D.
Washington University School of Medicine
Ulrich H. von Andrian, M.D., Ph.D.
Harvard Medical School
Robert H. Vonderheide, M.D., D.Phil.
University of Pennsylvania
Hao Wu, Ph.D.
Boston Children's Hospital & Harvard Medical School
Cassian Yee, M.D.
The University of Texas MD Anderson Cancer Center
Rolf M. Zinkernagel, M.D., Ph.D.
University of Zurich
Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link
Top